Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 248 | 2020 |
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections J Hellewell, TW Russell, R Beale, G Kelly, C Houlihan, E Nastouli, ... BMC medicine 19, 1-10, 2021 | 140 | 2021 |
Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals AT Caputo, DS Alonzi, L Marti, IB Reca, JL Kiappes, WB Struwe, A Cross, ... Proceedings of the National Academy of Sciences 113 (32), E4630-E4638, 2016 | 81 | 2016 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease B Canal, AW McClure, JF Curran, M Wu, R Ulferts, F Weissmann, J Zeng, ... Biochemical Journal 478 (13), 2445-2464, 2021 | 61 | 2021 |
Interdomain conformational flexibility underpins the activity of UGGT, the eukaryotic glycoprotein secretion checkpoint P Roversi, L Marti, AT Caputo, DS Alonzi, JC Hill, KC Dent, A Kumar, ... Proceedings of the National Academy of Sciences 114 (32), 8544-8549, 2017 | 56 | 2017 |
Core control principles of the eukaryotic cell cycle S Basu, J Greenwood, AW Jones, P Nurse Nature 607 (7918), 381-386, 2022 | 48 | 2022 |
Scalable and robust SARS-CoV-2 testing in an academic center J Aitken, K Ambrose, S Barrell, R Beale, G Bineva-Todd, D Biswas, ... Nature biotechnology 38 (8), 927-931, 2020 | 39 | 2020 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase S Basu, T Mak, R Ulferts, M Wu, T Deegan, R Fujisawa, KW Tan, CT Lim, ... Biochemical Journal 478 (13), 2481-2497, 2021 | 36 | 2021 |
CDK control pathways integrate cell size and ploidy information to control cell division JO Patterson, S Basu, P Rees, P Nurse Elife 10, e64592, 2021 | 20 | 2021 |
The hydrophobic patch directs cyclin B to centrosomes to promote global CDK phosphorylation at mitosis S Basu, EL Roberts, AW Jones, MP Swaffer, AP Snijders, P Nurse Current Biology 30 (5), 883-892. e4, 2020 | 20 | 2020 |
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy S Balestrini, MJ Koepp, S Gandhi, HM Rickman, GY Shin, CF Houlihan, ... Epilepsy & Behavior 115, 107602, 2021 | 16 | 2021 |
Structural insights into the broad-spectrum antiviral target endoplasmic reticulum alpha-glucosidase II AT Caputo, DS Alonzi, JL Kiappes, WB Struwe, A Cross, S Basu, B Darlot, ... Dengue and Zika: Control and Antiviral Treatment Strategies, 265-276, 2018 | 8 | 2018 |
Dengue and Zika: Control and Antiviral Treatment Strategies AT Caputo, DS Alonzi, JL Kiappes, WB Struwe, A Cross, S Basu, B Darlot, ... Advances in experimental medicine and biology 1062, 265-276, 2018 | 7 | 2018 |
CDK activity at the centrosome regulates the cell cycle EL Roberts, J Greenwood, N Kapadia, T Auchynnikava, S Basu, P Nurse Cell Reports 43 (4), 2024 | 1 | 2024 |
A CDK activity buffer ensures mitotic completion S Basu, JO Patterson, TU Zeisner, P Nurse Journal of Cell Science 135 (12), jcs259626, 2022 | 1 | 2022 |
A hybrid control model for the eukaryotic cell cycle S Basu, I Hagan Nature, 2022 | | 2022 |
The regulation of CDK activity by cyclins S Basu Imperial College London, 2021 | | 2021 |